Inaktiver Wert

Algeta ASA Aktie

Aktien

Dauer

Zeitraum

Stil

Actavis : Factbox - M&A frenzy transforming global pharma	06.05.14
Actavis : M&A frenzy in healthcare sector	06.05.14
Algeta ASA : UK cost agency says 'no' to Bayer prostate cancer drug Xofigo	24.03.14
Algeta ASA : Bayer clinches $2.9 billion deal for Norway's Algeta	24.02.14
Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid	19.12.13

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	-1,65 %	103 Mrd.
REGENERON PHARMACEUTICALS, INC.	+6,75 %	101 Mrd.
ARGENX SE	+6,64 %	23,07 Mrd.
BIONTECH SE	-12,60 %	22,23 Mrd.
GENMAB A/S	-4,64 %	18,05 Mrd.
WUXI APPTEC CO., LTD.	-39,98 %	17,18 Mrd.
BEIGENE, LTD.	-10,17 %	16,94 Mrd.
NEUROCRINE BIOSCIENCES, INC.	+6,12 %	14,07 Mrd.
SAREPTA THERAPEUTICS, INC.	+35,47 %	12,35 Mrd.